98 related articles for article (PubMed ID: 28123783)
21. Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?
Ramiro S; Landewé R; van der Heijde D; Harrison D; Collier D; Michaud K
RMD Open; 2015; 1(1):e000155. PubMed ID: 26629366
[TBL] [Abstract][Full Text] [Related]
22. Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors.
Finzel S; Kraus S; Schmidt S; Hueber A; Rech J; Engelke K; Englbrecht M; Schett G
Ann Rheum Dis; 2013 Jul; 72(7):1176-81. PubMed ID: 22915620
[TBL] [Abstract][Full Text] [Related]
23. TNFi Cycling Versus Changing Mechanism of Action in TNFi-Experienced Patients: Result of the Corrona CERTAIN Comparative Effectiveness Study.
Curtis JR; Kremer JM; Reed G; John AK; Pappas DA
ACR Open Rheumatol; 2022 Jan; 4(1):65-73. PubMed ID: 34741435
[TBL] [Abstract][Full Text] [Related]
24. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.
Chang CY; Meyer RM; Reiff AO
Arthritis Care Res (Hoboken); 2015 May; 67(5):658-66. PubMed ID: 25220674
[TBL] [Abstract][Full Text] [Related]
25. Real-World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; O'Brien J; Middaugh N; Kricorian G; Stryker S; Collier DH; Ogdie A
ACR Open Rheumatol; 2023 Aug; 5(8):388-398. PubMed ID: 37356824
[TBL] [Abstract][Full Text] [Related]
26. Cycling versus swapping strategies in psoriatic arthritis: results from the rheumatic diseases Portuguese register.
Guimarães F; Ferreira M; Soares C; Parente H; Matos CO; Costa R; Oliveira D; Abreu C; Teixeira R; Azevedo S; Dias JM; Araújo F; Ferreira CC; Santos FC; Fontes T; Faria M; Silva L; Chícharo A; Nero P; Santos H; Sepriano A; Santos-Faria D; Tavares-Costa J
ARP Rheumatol; 2023 Jun; ():. PubMed ID: 37728133
[TBL] [Abstract][Full Text] [Related]
27. Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden.
Hellgren K; Smedby KE; Backlin C; Sundstrom C; Feltelius N; Eriksson JK; Baecklund E; Askling J
Arthritis Rheumatol; 2014 May; 66(5):1282-90. PubMed ID: 24782185
[TBL] [Abstract][Full Text] [Related]
28. Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy.
Sebastian A; Wojtala P; Lubiński Ł; Mimier M; Chlebicki A; Wiland P
Reumatologia; 2017; 55(4):157-162. PubMed ID: 29056769
[TBL] [Abstract][Full Text] [Related]
29. Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study.
Fagerli KM; Lie E; van der Heijde D; Heiberg MS; Kalstad S; Rødevand E; Mikkelsen K; Lexberg AS; Kvien TK
Ann Rheum Dis; 2013 Nov; 72(11):1840-4. PubMed ID: 23562987
[TBL] [Abstract][Full Text] [Related]
30. Gender differences in biologic treatment outcomes-a study of 1750 patients with psoriatic arthritis using Danish Health Care Registers.
Højgaard P; Ballegaard C; Cordtz R; Zobbe K; Clausen M; Glintborg B; Kristensen LE; Dreyer L
Rheumatology (Oxford); 2018 Sep; 57(9):1651-1660. PubMed ID: 29893926
[TBL] [Abstract][Full Text] [Related]
31. Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort.
Ciurea A; Exer P; Weber U; Tamborrini G; Steininger B; Kissling RO; Bernhard J; Scherer A;
Arthritis Res Ther; 2016 Mar; 18():71. PubMed ID: 27000865
[TBL] [Abstract][Full Text] [Related]
32. Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitors.
Kim YJ; Kim YG; Shim TS; Koo BS; Hong S; Lee CK; Yoo B
Rheumatology (Oxford); 2014 Aug; 53(8):1477-81. PubMed ID: 24681840
[TBL] [Abstract][Full Text] [Related]
33. Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA.
Iannone F; Lopriore S; Bucci R; Scioscia C; Anelli MG; Notarnicola A; Lapadula G
Scand J Rheumatol; 2015 May; 44(3):192-9. PubMed ID: 25564882
[TBL] [Abstract][Full Text] [Related]
34. Etanercept and adalimumab treatment patterns in psoriatic arthritis patients enrolled in a commercial health plan.
Chastek B; Fox KM; Watson C; Gandra SR
Adv Ther; 2012 Aug; 29(8):691-7. PubMed ID: 22903239
[TBL] [Abstract][Full Text] [Related]
35. Sex Differences in the Patterns of Systemic Agent use Among Patients With Psoriasis: A Retrospective Cohort Study in Quebec, Canada.
Milan R; LeLorier J; Brouillette MJ; Holbrook A; Litvinov IV; Rahme E
Front Pharmacol; 2022; 13():810309. PubMed ID: 35242034
[No Abstract] [Full Text] [Related]
36. Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry.
Glintborg B; Højgaard P; Lund Hetland M; Steen Krogh N; Kollerup G; Jensen J; Chrysidis S; Jensen Hansen IM; Holland-Fischer M; Højland Hansen T; Nilsson C; Espesen J; Nordin H; Rasmussen Loft AG; Pelck R; Lorenzen T; Flejsborg Oeftiger S; Unger B; Jaeger F; Mosborg Petersen P; Rasmussen C; Dreyer L
Rheumatology (Oxford); 2016 Apr; 55(4):659-68. PubMed ID: 26628579
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register.
Chatzidionysiou K; Askling J; Eriksson J; Kristensen LE; van Vollenhoven R;
Ann Rheum Dis; 2015 May; 74(5):890-6. PubMed ID: 24431398
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry.
Harrold LR; Reed GW; Shewade A; Magner R; Saunders KC; John A; Kremer JM; Greenberg JD
J Rheumatol; 2015 Jul; 42(7):1090-8. PubMed ID: 25934829
[TBL] [Abstract][Full Text] [Related]
39. Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry.
Manders SH; van de Laar MA; Rongen-van Dartel SA; Bos R; Visser H; Brus HL; Jansen T; Vonkeman HE; van Riel PL; Kievit W
RMD Open; 2015; 1(1):e000147. PubMed ID: 26535151
[TBL] [Abstract][Full Text] [Related]
40. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.
Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LT; Kristensen LE; Feltelius N; Hetland ML; Askling J;
Ann Rheum Dis; 2017 Jan; 76(1):105-111. PubMed ID: 27147709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
